Alerts will be sent to your verified email
Verify Email
MOREPENLAB
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Morepen Laboratories is a pharmaceutical company manufacturing APis, Home Diagnostics, and OTC products. They specialize in anti-allergy drug Loratadine and are prominent in Blood Glucose Monitors and Blood Pressure Monitors domestically.
Morepen Laboratories major competitors are IOL Chem & Pharma, Solara Active Pharma, SMS Pharmaceuticals, Hester Biosciences, Bajaj Healthcare, Themis Medicare, NGL Fine-Chem.
Market Cap of Morepen Laboratories is ₹2,639 Crs.
While the median market cap of its peers are ₹1,733 Crs.
Morepen Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Mar Jun Sep | Dec | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Sep | Sep | Dec | |||||||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Jul Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | |||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Sep Dec | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar | Dec | ||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
